| 摘要: | 佳世達以私募換股結盟大江基因醫學，擴大其基因檢測專利業務，並積極參與精準醫療產業的發展。大江基因醫學在基因檢測產業，擁有相當出色的技術與研發優勢，累積長期研發經驗和技術能量，具有龐大的研發和專利技術儲備，佳世達以私募換股大江基因醫學，結合其技術優勢、成熟的營運管理和品牌影響力，提升自身在跨足生物科技產業的競爭優勢。
佳世達私募換股大江基因醫學，符合國際產業發展的潛在趨勢。近年來，生物科技研發逐步成為全球經濟競爭力中，新的增長與發展點。透過私募換股，佳世達不僅可以快速提升其在基因檢測專利業務上的實力，更可以提升公司在精準醫療產業中的地位，並希望具備國際間推動生物科技產業成長的重要力量。
佳世達私募換股大江基因醫學的成功範例，加快佳世達在精準醫療產業中的發展，更標示著電子科技跨領域創新日臻進步，生物科技產業將是未來的重要發展領域之一，佳世達採取私募換股的決定，有助於提升臺灣在全球生物科技產業中的地位與競爭力，提供其他產業順利跨領域合作雙贏的借鏡。
Qisda has formed an alliance with Dajiang Genetic Medicine through a share exchange to expand its genetic testing patent business and actively participate in the development of the precision medicine industry. Dajiang Genetic Medicine has excellent technology and R&D advantages in the genetic testing industry. It has accumulated long-term R&D experience and technical energy, and has a huge R&D and patented technology reserve. Qisda exchanged private equity for shares in Dajiang Genetic Medicine, combining its technical advantages and maturity. operation management and brand influence to enhance its competitive advantage in the biotechnology industry.
Qisda's private equity exchange for shares in Dajiang Genetic Medicine is in line with the potential trend of international industry development. In recent years, biotechnology research and development has gradually become a new growth and development point in global economic competitiveness. Through private placement and stock exchange, Qisda can not only quickly improve its strength in the genetic testing patent business, but also enhance the company's position in the precision medicine industry, and hopes to become an important force in promoting the growth of the biotechnology industry internationally.
The successful example of Qisda's private equity swap for Dajiang Genetic Medicine has accelerated Qisda's development in the precision medicine industry, and also marked the progress of cross-field innovation in electronic technology. The biotechnology industry will be one of the important development areas in the future. Qisda has adopted The decision to conduct a private equity exchange will help enhance Taiwan's status and competitiveness in the global biotechnology industry, and provide other industries with a reference for smooth cross-field cooperation and win-win results. |
